Issue 6/2005
Content (8 Articles)
Leading Article
Incorporation of uncertainty in health economic modelling studies
Anthony O’Hagan, Christopher McCabe, Ron Akehurst, Alan Brennan, Andrew Briggs, Karl Claxton, Elisabeth Fenwick, Dennis Fryback, Mark Sculpher, David Spiegelhalter, Andrew Willan
Commentary
Health utilities in Alzheimer’s disease and implications for cost-effectiveness analysis
Peter J. Neumann
Review Article
The economics of topical immunomodulators for the treatment of atopic dermatitis
William Abramovits, Mark Boguniewicz, Amy S. Paller, Diane L. Whitaker-Worth, Mary M. Prendergast, Michael Tokar, Kuo B. Tong
Review Article
Bipolar disorder and health-related quality of life
Dennis A. Revicki, Louis S. Matza, Emuella Flood, Andrew Lloyd
Original Research Article
The cost effectiveness of infliximab for severe treatment-resistant rheumatoid arthritis in the UK
Marco Barbieri, John B. Wong, Michael Drummond
Original Research Article
Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease
Michael Spencer, Andrew H. Briggs, Ronald F. Grossman, Laureen Rance